Cancer Committee/Care Quality
Your care is in the best of hands. Our Cancer Committee leads the cancer program by setting goals, monitoring cancer related activity, evaluating patient outcomes, and improving patient care. We offer weekly clinical cancer conferences that provide a forum for patient consultation and contribute to physician and staff education. We also maintain an ongoing quality improvement program, which is the mechanism for evaluating and improving patient outcomes. In addition, we have a cancer registry and database that is the basis for monitoring the quality of care and cancer statistics.
Cancer Committee Members
-
Julie Smith, MD (cancer committee chair, medical director of the Cancer Care service line)
-
Rachelle Boyd (tumor registry)
-
Vaishali Bhide, RN (Care Management Dept.)
-
Thomas Carlson, MD (Radiation Oncology Dept.)
-
Carl Kjobech, MD (Wellness Place)
-
Anna Hansen, MD (medical director of the Radiology service line)
-
Jessie Sanders (American Cancer Society)
-
Jennifer Jorgensen, MD (president of the Wenatchee Valley Medical Group)
-
Barbara Kane, RN (Hospice Dept.)
-
Katie Kemble, DNP (Medical Oncology Dept., survivorship program)
-
Daniel Kerr, MD (lab administrator)
-
Kim Hinson, RN (oncology nurse navigator)
-
Celeste Van Houten, MA-C (Diagnostic Imaging Dept.)
Clinical Cancer Conference
Also known as the Tumor Board, these weekly conferences are held to discuss challenging cancer diagnoses in a multispecialty team setting. Every week, oncologists, radiation oncologists, surgeons, pathologists, radiologists, primary care physicians and other relevant specialty medicine physicians come together to discuss the patient’s care and treatment plan. Nursing staff, pharmacists, research and other allied health professionals are also in attendance. We also have the capability of involving our physicians in Moses Lake, Omak and other outreach clinics.
The Clinical Cancer Conference team carefully reviews each patient’s cancer and clinical history, pathology/radiology findings and surgical details if applicable. The most current diagnostic and treatment pathways as well as available clinical research trials and cancer staging are discussed. A plan of action and recommendations by the group are submitted by the coordinator to each member of the patient’s cancer-care team.
Reports
- 2018 Oncology Annual Report
- 2017 Oncology Annual Report
- 2016 Oncology Annual Report
- 2015 Oncology Annual Report